Skip to main content
Caplight Logo









TissueLabs

TissueLabs

Private
BellinzonaHealthcare & Life Scienceshttps://www.tissuelabs.com/

Last Round

Pre Seed

Mar 22, 2024

Total Funding Raised

$2.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

TissueLabs is a biotechnology company that provides a platform for creating tissues and organs in the lab, offering 3D bioprinters, tissue-specific biomaterials, and services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, 3D Printing, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

3D bioprintingbioprintingtissue engineering3D cell cultureregenerative medicinebiomaterialshydrogelsdrug discoverylab equipmentbiotech toolsorgan-on-a-chipbiofabricationdecellularized matrixbiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TissueLabs Comparables

Compare TissueLabs with similar companies based on industry and business-model similarity.

TissueLabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
3D Biotechnology Solutions
86%
Regemat 3D
86%
Brinter
84%

TissueLabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 22, 2024
SeedAug 7, 2020

Key People

Founding team and executive leadership

Gabriel Liguori

Founder And CEO

Founding Team

Felipe chippari

Chief Financial Officer

Executive Team

TissueLabs Investors

Notable investors and investment history

TissueLabs investors
InvestorRounds
MIT Alumni AngelsPre Seed
CietecSeed
Mergus VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 100% MoM, reaching 2.8K.

  • Nov 8, 2025

    Monthly visitors grew 220% MoM, reaching 5.3K.

TissueLabs Filings

Explore SEC and related filing metadata, where available.

TissueLabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TissueLabs's valuation, stock price, and market status.

Is TissueLabs a public or private company?

TissueLabs is a private company.

What is the current stock price of TissueLabs?

TissueLabs is a private company with no public stock price. No recent secondary market data is available.

How much is TissueLabs worth (valuation)?

Valuation information for TissueLabs is not publicly available.

Can I buy TissueLabs stock?

TissueLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TissueLabs's last funding round?

TissueLabs's most recent funding round was Pre Seed on March 22, 2024.

Who are the main investors in TissueLabs?

Key investors in TissueLabs include Mergus Ventures.

Will TissueLabs IPO soon?

No public IPO plans have been announced for TissueLabs.

How can I track TissueLabs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TissueLabs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBellinzona
Employee Range17
Year Founded2019
Last FundingMar 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?